With Experimental Zika Virus Vaccines In Human Clinical Trials, Scientists Wonder Whether Market Will Exist When Shots Approved

STAT: A Zika vaccine is being developed at warp speed, but will there be a market for it?
“…[D]espite funding delays from a fractious pre-election Congress, three experimental Zika vaccines are already being tested in people; another four or five should start human trials between now and next fall. … Let’s be clear: That is warp speed for vaccine development, especially in a case, such as this, where the race commenced from a standing start. But will there be a market for a Zika vaccine when the work is done? That question hangs over this work…” (Branswell, 12/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.